Diabetes Mellitus: Target Enzymes and Drugs
Editat de Ashish Kumar Tewari, Manisha Nidharen Limba Engleză Paperback – iun 2025
This type of research is needed for the understanding of the effects of drugs in order to improve future treatments and care of patients with diabetes.
- Describes Pathophysiology and the Types of Diabetes
- Discusses Insulin and Insulin Mechanisms in Diabetes Mellitus
- Offers information on Antidiabetic drugs from Natural Sources
- Includes the FDA approved antidiabetic drugs and their adverse effects
Preț: 782.06 lei
Preț vechi: 859.40 lei
-9% Nou
Puncte Express: 1173
Preț estimativ în valută:
149.65€ • 154.39$ • 124.88£
149.65€ • 154.39$ • 124.88£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443291296
ISBN-10: 0443291292
Pagini: 370
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0443291292
Pagini: 370
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Introduction to Diabetes Mellitus
2. Dipeptidyl Peptidase-4 (DPP-4) Enzyme in Diabetes Mellitus
3. PPAR-γ (Peroxisome proliferator-activated receptor) receptor in Diabetes Mellitus
4. α-glucosidase in Diabetes Mellitus
5. Sodium-glucose cotransporter-2 (SGLT2) in Diabetes Mellitus
6. Insulin in Diabetes Mellitus
7. Glucagon-like peptide-1 receptor in Diabetes Mellitus
8. Amylin in Diabetes Mellitus
9. Miscellaneous drug combinations in Diabetes Mellitus
10. Antidiabetic drugs from Natural Sources
11. Future challenges in targeted drug for Diabetes Mellitus
2. Dipeptidyl Peptidase-4 (DPP-4) Enzyme in Diabetes Mellitus
3. PPAR-γ (Peroxisome proliferator-activated receptor) receptor in Diabetes Mellitus
4. α-glucosidase in Diabetes Mellitus
5. Sodium-glucose cotransporter-2 (SGLT2) in Diabetes Mellitus
6. Insulin in Diabetes Mellitus
7. Glucagon-like peptide-1 receptor in Diabetes Mellitus
8. Amylin in Diabetes Mellitus
9. Miscellaneous drug combinations in Diabetes Mellitus
10. Antidiabetic drugs from Natural Sources
11. Future challenges in targeted drug for Diabetes Mellitus